QLife

With diabetes and metabolic dysfunction-associated steatotic liver disease (MASLD) also called "fatty-liver disease" on the rise, traditional care models have struggled with challenges such as overreliance on medication, hospital-centric treatment, and fragmented follow-up. This project introduces a full-cycle integrated management solution that shifts the paradigm from passive treatment to proactive health management-powered by the Egoo Health platform.

Egoo: Bringing Professional Testing Home

The Egoo testing platform enables patients to perform professional-grade companion diagnostic tests at home, including key indicators such as HbA1c, urinary microalbumin, creatinine, and blood lipids. Its high accuracy, ease of use, and portability eliminate the need for frequent hospital visits, bridging the "last mile" in continuous monitoring and improving convenience and continuity for patients.

AI-Driven Personalized Care

Complementing Egoo's at-home testing capabilities, the project introduces an AI-powered digital twin health management platform. This innovative system combines expertise from endocrinologists, general practitioners, nutritionists, exercise specialists, and psychological counselors to deliver real-time monitoring, personalized nutrition plans, behavioral guidance, and lifestyle support. Patients benefit from a unique "specialist co-management + digital assistant" model, ensuring comprehensive and sustained care beyond the hospital setting.

A New Era in Chronic Disease Management

This collaboration marks a significant step toward a new model of "home testing + intelligent management + long-term maintenance." By integrating advanced diagnostics with AI-driven health services, the project sets a scalable blueprint for precision chronic disease management-delivering more efficient, convenient, and effective solutions for patients.

"We are thrilled to see Egoo at the heart of such an ambitious initiative in China. This project exemplifies how technology can empower patients and healthcare providers to move beyond traditional care models. By combining accurate home testing with AI-driven health management, we are helping to redefine chronic disease care for millions of people," said Thomas Warthoe, CEO of Qlife.

For more information, please contact: 

Thomas Warthoe Chief Executive Officer (CEO)
Phn: +45 21 63 35 34
E-mail: tw@egoo.health